Dogwood Therapeutics (DWTX) Competitors $4.93 +0.04 (+0.82%) Closing price 03:46 PM EasternExtended Trading$4.91 -0.02 (-0.41%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DWTX vs. SCYX, OKUR, SNTI, XLO, RANI, MURA, RENB, PYRGF, HYPD, and MRSNShould you be buying Dogwood Therapeutics stock or one of its competitors? The main competitors of Dogwood Therapeutics include SCYNEXIS (SCYX), OnKure Therapeutics (OKUR), Senti Biosciences (SNTI), Xilio Therapeutics (XLO), Rani Therapeutics (RANI), Mural Oncology (MURA), Renovaro (RENB), PyroGenesis Canada (PYRGF), Hyperion DeFi (HYPD), and Mersana Therapeutics (MRSN). These companies are all part of the "pharmaceutical products" industry. Dogwood Therapeutics vs. Its Competitors SCYNEXIS OnKure Therapeutics Senti Biosciences Xilio Therapeutics Rani Therapeutics Mural Oncology Renovaro PyroGenesis Canada Hyperion DeFi Mersana Therapeutics SCYNEXIS (NASDAQ:SCYX) and Dogwood Therapeutics (NASDAQ:DWTX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings. Do analysts recommend SCYX or DWTX? Dogwood Therapeutics has a consensus price target of $10.00, suggesting a potential upside of 102.84%. Given Dogwood Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Dogwood Therapeutics is more favorable than SCYNEXIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SCYNEXIS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Dogwood Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SCYX or DWTX more profitable? Dogwood Therapeutics has a net margin of 0.00% compared to SCYNEXIS's net margin of -599.05%. Dogwood Therapeutics' return on equity of 0.00% beat SCYNEXIS's return on equity.Company Net Margins Return on Equity Return on Assets SCYNEXIS-599.05% -43.04% -28.21% Dogwood Therapeutics N/A N/A -27.41% Which has better valuation and earnings, SCYX or DWTX? Dogwood Therapeutics has lower revenue, but higher earnings than SCYNEXIS. SCYNEXIS is trading at a lower price-to-earnings ratio than Dogwood Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSCYNEXIS$3.75M12.30-$21.29M-$0.40-2.75Dogwood TherapeuticsN/AN/A-$12.35M-$18.78-0.26 Which has more volatility & risk, SCYX or DWTX? SCYNEXIS has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Comparatively, Dogwood Therapeutics has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Do insiders and institutionals have more ownership in SCYX or DWTX? 54.4% of SCYNEXIS shares are held by institutional investors. Comparatively, 9.1% of Dogwood Therapeutics shares are held by institutional investors. 4.9% of SCYNEXIS shares are held by insiders. Comparatively, 3.9% of Dogwood Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor SCYX or DWTX? In the previous week, SCYNEXIS and SCYNEXIS both had 1 articles in the media. Dogwood Therapeutics' average media sentiment score of 1.91 beat SCYNEXIS's score of 1.89 indicating that Dogwood Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment SCYNEXIS Very Positive Dogwood Therapeutics Very Positive SummaryDogwood Therapeutics beats SCYNEXIS on 10 of the 14 factors compared between the two stocks. Get Dogwood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DWTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DWTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DWTX vs. The Competition Export to ExcelMetricDogwood TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.35M$3.15B$5.78B$10.19BDividend YieldN/A2.33%5.73%4.61%P/E Ratio-0.2621.2474.8626.40Price / SalesN/A456.43540.53124.73Price / CashN/A44.4425.8129.91Price / Book-0.659.6413.256.28Net Income-$12.35M-$53.20M$3.29B$270.38M7 Day Performance1.71%0.44%0.47%2.70%1 Month PerformanceN/A4.26%4.60%5.99%1 Year PerformanceN/A9.43%73.42%25.94% Dogwood Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DWTXDogwood Therapeutics2.0921 of 5 stars$4.93+0.8%$10.00+102.8%N/A$9.35MN/A-0.265Positive NewsSCYXSCYNEXIS1.6233 of 5 stars$0.92+3.0%N/A-23.3%$37.31M$3.26M-2.2960OKUROnKure Therapeutics3.7409 of 5 stars$2.63-4.4%$32.33+1,129.4%N/A$37.21MN/A-0.55N/ASNTISenti Biosciences3.3708 of 5 stars$1.32-5.0%$8.50+543.9%-56.0%$36.36M$2.56M-0.154Positive NewsShort Interest ↓XLOXilio Therapeutics2.7651 of 5 stars$0.70-0.6%$3.00+331.2%-10.2%$36.27M$6.34M-0.9270RANIRani Therapeutics3.1913 of 5 stars$0.50-0.4%$7.33+1,366.7%-78.9%$36.09M$1.03M-0.55110Positive NewsShort Interest ↓MURAMural Oncology2.5484 of 5 stars$2.07flat$12.00+479.7%-36.8%$35.86MN/A-0.24119Short Interest ↑RENBRenovaro0.8703 of 5 stars$0.19-8.9%N/A-69.7%$35.54MN/A-0.2420Gap UpHigh Trading VolumePYRGFPyroGenesis CanadaN/A$0.19-1.5%N/A-67.9%$35.11M$9.14M-3.1290Gap UpHigh Trading VolumeHYPDHyperion DeFi0.384 of 5 stars$6.48+5.5%$2.00-69.1%-65.1%$34.97M$60K-0.1140News CoverageGap DownMRSNMersana Therapeutics4.187 of 5 stars$7.04+3.2%$56.60+704.0%-86.5%$34.04M$40.50M-0.48150Positive NewsGap Up Related Companies and Tools Related Companies SCYX Alternatives OKUR Alternatives SNTI Alternatives XLO Alternatives RANI Alternatives MURA Alternatives RENB Alternatives PYRGF Alternatives HYPD Alternatives MRSN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DWTX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DWTX Stock Alerts